Cerebral hemorrhage after passive anti-aβ immunotherapy

Science

Volumn 298, Issue 5597, 2002, Pages 1379-

  Pfeifer, M ^a   Boncristiano, S ^a   Bondolfi, L ^a   Stalder, A ^a   Deller, T ^a   Staufenbiel, M ^a   Mathews, P M ^a   Jucker, M ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FORMIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; UNCLASSIFIED DRUG;

IMMUNE SYSTEM;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOTHERAPY; INCIDENCE; MALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SHORT SURVEY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES, MONOCLONAL; CAPILLARY PERMEABILITY; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MALE; MICE; MICE, TRANSGENIC; NEOCORTEX; PEPTIDE FRAGMENTS;

ANIMALIA; MUS MUSCULUS;

EID: 0037112201     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1078259     Document Type: Short Survey

References (11)

1. D. Schenk, Nature Rev. Neurosci. 3, 824 (2002).
2. C. Sturchler-Pierrat et al., Proc, Natl. Acad. Sci. U.S.A. 94, 13287 (1997).
3. M. E. Calhoun et al., Proc. Natl. Acad. Sci. U.S.A. 96, 14088 (1999).
4. See supplementary material on Science Online.
5. D. T. Winkler et al., J. Neurosci. 21, 1619 (2001).
6. A. Maeda et al., Stroke 24, 1857 (1993).
7. D. Paris et al., Neurobiol. Aging 21, 183 (2000).
8. J.F. Poduslo et al., Neuroreport 12, 3197 (2001).
9. K. A. Jellinger, J. Neural Transm. 109, 813 (2002).
10. S. M. Greenberg, Neurology 51, 690 (1998).
11. Supported by the Swiss National Science Foundation, the Alzheimer Forschung Initiative, and the National Institute on Aging. We thank D. Tsakiris, M. Mihatsch, A. Probst, D. Winkler, M. Zurini, G. Burbach, M. Mercken, L. Walker, M. Herzig, J. Ghiso, and S. Schmidt for advice and help.